| Ambetter Health Texas Superior Marketplace Clinical | Eribulin Mesylate | 2025-11-01 |
| Ambetter Health Texas Superior Medicaid Clinical | No Coverage Criteria, Recent Label Changes Pending | 2025-11-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Obinutuzumab | 2025-11-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Off-Label Use | 2025-11-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Palopegteriparatide | 2025-11-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Panitumumab | 2025-11-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Pasireotide | 2025-11-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Pegaspargase, Calaspargase Pegol-mknl | 2025-11-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Pegvisomant | 2025-11-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Plasminogen, Human-tvmh | 2025-11-01 |